Tag Archives: Women’s

Online Course on Women’s Mental Health Starts Next Week: November 4, 2019

This fall, we are offering an online course on women’s mental health. This online course will focus on the diagnosis and treatment of psychiatric disorders in women across the reproductive lifespan. Specialized knowledge is necessary to tailor treatments to reproductive events such as pregnancy and pregnancy planning, the postpartum, breastfeeding, the menopausal transition, and menstrual… Read More »

Weekly Roundup for OCTOBER 25, 2019: Recent Publications in Women’s Mental Health

The role of prenatal, obstetric, and post-partum factors in the parenting stress of mothers and fathers of 9-month old infants. Matvienko-Sikar K, Murphy G, Murphy M.  J Psychosom Obstet Gynaecol. 2018 Mar;39(1):47-55. Mothers reported higher levels of parenting stress than fathers (p?<?0.001). Maternal parenting stress was predicted by attachment, own health status, average sleep, occupation,… Read More »

Weekly Roundup for SEPTEMBER 6, 2019: Recent Publications in Women’s Mental Health

Amygdala and affective responses to infant pictures; comparing depressed and non-depressed mothers and non-mothers. Dudin A, Wonch KE, Davis AD, Steiner M, Fleming AS, Hall GB.  J Neuroendocrinol. 2019 Sep 5:e12790. Women with PPD show an enhanced amygdala response to affectively positive infant pictures, but not to affectively positive pictures of scenery. Women with depression… Read More »

Upcoming MGH Conference on Women’s Mental Health – October 17, 2019

We are excited to announce that we will be offering a new one day course in Women’s Mental Health in Boston on Thursday, October 17th.  This is the day preceding the Annual Psychopharmacology Conference (October 18-20, 2019). This course will focus on the diagnosis and treatment of psychiatric disorders in women across the reproductive lifespan.… Read More »

Weekly Roundup for JULY  5, 2019: Recent Publications in Women’s Mental Health

In a large study from France (Blotière et al, 2019), researchers demonstrated that exposure to monotherapy with valproic acid was associated with 8 specific types of major congenital malformations (e.g., spina bifida, OR 19.4), and exposure to topiramate was associated with an increased risk of cleft lip (OR 6.8). No significant associations were found for… Read More »